Bruker Cellular Analysis, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q2 2023.

Location
Emeryville, CA
Fiscal year end
31 December
Latest financial report
14 Aug 2023

Shareable Research Card

Bruker Cellular Analysis, Inc. Financial Facts

Bruker Cellular Analysis, Inc. has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q2 2023
Latest reported value
Return On Equity -87%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Open stable link Open latest 10-Q/10-K hub Which companies report the highest revenue?

Return Loop

Why revisit this company facts page

Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.

Latest source-backed update
Latest metrics period Q2 2023
Why come back
Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
  • Current latest metrics period: Q2 2023.
  • Most recent SEC facts end date on this page: 31 Jul 2023.
  • Save this filer to return when the next filing-backed metric period changes the picture.

Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.

Create account to save this filer Open latest 10-Q/10-K hub

Latest update

Latest update for Bruker Cellular Analysis, Inc.

New fact period available

Latest financial period: Q2 2023. Reopen this facts page to verify the newest reported period against the prior baseline.

Update date

14 Aug 2023

Page type

Company facts

Latest period

Q2 2023

SEC-backed company facts were refreshed from filings filed on 14 Aug 2023.

Open recent updates hub Open latest 10-Q/10-K hub

Benchmark Context

How Return On Equity compares

Return On Equity is up about 108% versus the comparable prior period. It sits below the lower quarter of the current industry benchmark sample.

Compared with

Compared with Bruker Cellular Analysis, Inc.'s recent history and the latest same-industry benchmark sample for the same metric.

Why this is notable

Use the history link to verify the prior-period change, then compare that metric with the current industry middle range if you want broader context.

  • Latest comparable period on this page: Q2 2023.
  • Current industry benchmark sample: 33 companies.
  • Open the metric history first if you want to verify the exact period-to-period change.

Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.

Open Revenues YoY history Which companies report the highest revenue?

How to read key metrics on this page

These short guides explain what the headline metrics mean, what to compare next, and where to open the live SEC-backed example for this company.

Plain-English Guide

How to read Revenue on this page

Revenue is the sales a company reports from customers before most expenses are subtracted.

Why people care

People start here to understand business scale and whether demand is growing before they ask about margins or cash flow.

How to read it

Check the latest reported period first, then compare the same quarter or year against prior periods so seasonality does not distort the story.

Compare next

Compare revenue with gross profit, operating income, and operating cash flow to see whether sales are turning into healthy economics.

Revenue can jump because of acquisitions, pricing changes, or revenue-recognition rules, and reporting periods may differ across companies.

Open a live SEC-backed example

Open Revenue guide

Plain-English Guide

How to read Net Income on this page

Net income is profit after operating costs, interest, taxes, and other non-operating items.

Why people care

It is the bottom-line profit figure many users recognize first, especially when they want to compare earnings with sales or cash flow.

How to read it

Use the same quarter or fiscal year comparison first, then check operating income or cash flow if the bottom line moved sharply.

Compare next

Compare it with operating income, EPS, and operating cash flow to see whether earnings are broad-based or driven by one-off items.

Net income can swing because of tax, financing, or accounting adjustments, so it is often less comparable than core operating metrics.

Open a live SEC-backed example

Open Net Income guide

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Create free account to save and revisit this page

Quick Takeaways

  • Bruker Cellular Analysis, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q2 2023.
  • Headline metric: Return On Equity -87%.

What Changed

  • Return On Equity YoY change: +108%.
  • Most recent SEC facts end date: 31 Jul 2023.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Source Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

See Original Filing

Latest SEC snapshot (2023-07-31) highlights Return On Equity -87.2%, Return On Assets -58.3%, and Operating Margin -168.9%.

Compare This Company Through SEC-backed Metrics

Use these links to compare Bruker Cellular Analysis, Inc. against other SEC filers on the same metric, then verify the company history from the paired facts page.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

33.3/100

Weak Confidence high

Return On Equity

-87%

Metric score 0.0/100

Return On Assets

-58%

Metric score 0.0/100

Financial Health

Current Ratio
2.24x
Quick Ratio
1.07x
Debt to Equity
0.65x

Strengths

Current Ratio, Quick Ratio, and Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-87%

YoY: +108%

Industry median: -32% (n=33)

View history

Return On Assets

-58%

YoY: +86%

Industry median: -35% (n=33)

View history

Operating Margin

-169%

YoY: +73%

Industry median: -117% (n=29)

View history

Current Ratio

2.24x

YoY: -66%

Industry median: 2.39x (n=34)

View history

Quick Ratio

1.07x

YoY: -81%

Industry median: 1.25x (n=30)

View history

Debt-to-equity

0.65x

YoY: +69%

Industry median: 0.37x (n=30)

View history

Revenues YoY

-17%

YoY:

Industry median: -0.07% (n=30)

View history

NetIncomeLoss YoY

-46%

YoY:

Industry median: -0.5% (n=31)

View history

Profitability

Metric Latest value YoY change
Return On Equity -87% +108%
Return On Assets -58% +86%
Operating Margin -169% +73%

Financial Health

Metric Latest value YoY change
Current Ratio 2.24x -66%
Quick Ratio 1.07x -81%
Debt-to-equity 0.65x +69%

Growth

Metric Latest value YoY change
Revenues YoY -17%
NetIncomeLoss YoY -46%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 99,296,604 +45%
Common Stock, Shares, Outstanding 99,113,089 +45%
Common Stock, Value, Issued $5,000 +25%
Weighted Average Number of Shares Outstanding, Basic 98,900,780 +45%
Weighted Average Number of Shares Outstanding, Diluted 98,900,780 +45%

Supporting Metrics

These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.

Metric Latest value YoY change
Accounts Receivable, after Allowance for Credit Loss, Current $14,375,000 +4.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax $50,000
Additional Paid in Capital $546,538,000 +13%
Amortization of Intangible Assets $577,000
Assets $178,332,000 -28%
Assets, Current $94,786,000 -51%
Cash and Cash Equivalents, at Carrying Value $30,964,000 -78%
Cash, Cash Equivalents, and Short-term Investments $31,000,000 -80%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31,057,000 -78%
Common Stock, Par or Stated Value Per Share 0 0%
Common Stock, Shares Authorized 300,000,000 0%
Common Stock, Shares, Issued 99,113,089 +45%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $124,462,000 -46%
Contract with Customer, Liability, Current $9,648,000 +11%
Contract with Customer, Liability, Noncurrent $876,000 -28%
Depreciation $9,204,000 +27%
Earnings Per Share, Basic -2 -21%
Earnings Per Share, Diluted -2 -21%
Employee-related Liabilities, Current $6,116,000 -4.4%
Goodwill $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $124,384,000 -46%
Income Tax Expense (Benefit) $147,000 +1175%
Intangible Assets, Net (Excluding Goodwill) $22,499,000
Interest Expense $2,475,000 +171%
Inventory, Net $41,455,000 +165%
Lessee, Operating Lease, Liability, to be Paid $32,991,000 +2.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,759,000 +3%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,297,000 +47%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,398,000 +20%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,952,000 +37%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,958,000 -18%
Liabilities $67,051,000 -9.7%
Liabilities and Equity $178,332,000 -28%
Liabilities, Current $42,225,000 +45%
Operating Income (Loss) $121,271,000 -43%
Operating Lease, Liability $28,968,000 +6.6%
Operating Lease, Liability, Current $5,018,000 +65%
Operating Lease, Liability, Noncurrent $23,950,000 -0.78%
Operating Lease, Right-of-Use Asset $26,224,000 +6.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 0%
Other Assets, Current $3,836,000 +19%
Other Assets, Noncurrent $2,020,000 -16%
Property, Plant and Equipment, Gross $64,924,000 +18%
Property, Plant and Equipment, Net $32,710,000 +12%
Research and Development Expense $35,219,000 -48%
Retained Earnings (Accumulated Deficit) $435,312,000 -40%
Revenue from Contract with Customer, Excluding Assessed Tax $71,817,000 -17%
Share-based Payment Arrangement, Expense $18,355,000 -20%
Stockholders' Equity Attributable to Parent $111,281,000 -36%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY